Neuroprotective Effects of Paeonia lactiflora Through the Regulation of Gut Dubosiella in an MPTP-Induced Parkinson’s Disease Mouse Model
- 1 January 2025
- journal article
- Published by World Scientific Pub Co Pte Ltd in The American Journal of Chinese Medicine
- Vol. 53 (03) , 833-862
Abstract
Emerging evidence suggests that changes in the composition of the gut microbiota may play an important role in the pathogenesis of Parkinson’s disease (PD). Paeonia lactiflora Pall., a traditional Chinese medicinal herb belonging to the genus Paeonia, is commonly used in Chinese medicinal practice for the treatment of PD. However, the specific mechanisms of its action remain poorly understood. This study aimed to further determine the neuroprotective properties of Paeonia lactiflora Pall. water extract (PWE) in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD model, and to investigate its potential implications for the pathogenesis of PD. A PD mouse model was established via the intraperitoneal administration of MPTP, followed by the assessment of motor function using behavioral tests. Western blotting and histopathological analysis were used to measure the levels of dopaminergic (DAergic) neurodegeneration-related factors in the midbrain (containing the substantia nigra (SN)) and striatum. 16S rRNA gene sequencing and metabolomic analysis were applied to identify differences in the gut microbiota and metabolites, respectively. Our results indicate that PWE effectively protects against MPTP-induced motor deficits, loss of DAergic neurons, blood-brain barrier (BBB) damage, and neuroinflammation in PD. The protective effects of PWE against PD are mediated through modulation of the gut microbiota, specifically by an increase in the abundance of the genus Dubosiella. In this study, we selected D. newyorkensis as a representative strain of the genus, and determined its therapeutic effects in an MPTP-induced PD mouse model. Our preliminary findings suggest that the neuroprotective effects of D. newyorkensis may be related to the production of serum indoleacetic acid.Keywords
Funding Information
- the Zhejiang Provincial Natural Science Foundation of China (LBY24H290001)
- The Medical Health Science and Technology Project of Zhejiang Provincial (2024KY1726)
- The Traditional Chinese Medicine Science and Technology Project of Zhejiang Provincial (2024ZF165, 2023ZR136)
- The Science and Technology Project of Shaoxing (2023A14011, 2022A14009)
This publication has 36 references indexed in Scilit:
- Protective mechanism of Paeonol on central nervous systemPhytotherapy Research, 2023
- Effects of albiflorin on oxidative stress and inflammatory responses in rats with acute spinal cord injuryImmunity, Inflammation and Disease, 2023
- Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal ChangesAnnals of Neurology, 2023
- Emerging insights between gut microbiome dysbiosis and Parkinson’s disease: Pathogenic and clinical relevanceAgeing Research Reviews, 2022
- Enhanced cultured diversity of the mouse gut microbiota enables custom-made synthetic communitiesCell Host & Microbe, 2022
- Vancomycin Pretreatment on MPTP-Induced Parkinson’s Disease Mice Exerts Neuroprotection by Suppressing Inflammation Both in Brain and GutJournal of Neuroimmune Pharmacology, 2022
- Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantationJournal of Neurology, 2021
- Parkinson Disease Epidemiology, Pathology, Genetics, and PathophysiologyClinics in Geriatric Medicine, 2020
- Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s DiseaseCell, 2016
- Gut microbiota are related to Parkinson's disease and clinical phenotypeMovement Disorders, 2014